Silvant Capital Management LLC Regenxbio Inc. Transaction History

Silvant Capital Management LLC

  • $2.07 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022
SELL
$19.35 - $35.04 $72,214 - $130,769
-3,732 Closed
0 $0
Q4 2021

Feb 07, 2022
SELL
$30.19 - $40.28 $7,215 - $9,626
-239 Reduced 6.02%
3,732 $122,000
Q3 2019

Nov 12, 2019
BUY
$31.84 - $50.88 $44,576 - $71,232
1,400 Added 54.45%
3,971 $141,000
Q1 2019

May 10, 2019
BUY
$40.82 - $62.45 $104,948 - $160,558
2,571 New
2,571 $147,000

Others Institutions Holding RGNX

# of Institutions
192
Shares Held
42.6M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $590M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email